Nattokinase and Spike Protein Inhibition
The mRNA and adenoviral DNA products were rolled out with no idea of how or when
the body would ever break down the genetic code. The synthetic mRNA carried on
lipid nanoparticles appears to be resistant to breakdown by human ribonucleases
by design so the product would be long-lasting and produce the protein product
of interest for a considerable time period.
This would be an advantage for a normal human protein being replaced in a rare genetic deficiency state (e.g., alpha galactosidase in Fabry’s disease). However, it is a big problem when the protein is the pathogenic SARS-CoV-2 spike. The adenoviral DNA (Janssen) should be broken down by deoxyribonuclease, however, this has not been exhaustively studied.
This leaves dissolution of spike protein as a therapeutic goal for the vaccine injured. With the respiratory infection, spike is processed and activated by cellular proteases including transmembrane serine protein 2, cathepsin, and furin. With vaccination, these systems may be avoided by systemic administration and production of spike protein within cells. As a result, the pathogenesis of vaccine injury syndromes is believed to be driven by accumulation of spike protein in cells, tissues, and organs.
The Infectious Disease Society of America (IDSA) estimates that the
spike proteins that were generated by COVID-19 vaccines last up to a few weeks, like other proteins made by the body. The immune system quickly
identifies, attacks and destroys the spike proteins because it
recognizes them as not part of you. This "learning the enemy"
process is how the immune system figures out how to defeat the real
coronavirus. It remembers what it saw and when you are exposed to
coronavirus in the future it can rapidly mount an effective immune
response.
Although the research on nattokinase and its effect on COVID-19 is still
in its infancy, the ability of nattokinase to degrade spike proteins
combined with its anti-clotting properties makes it an exciting topic for
further study.
Some researchers and clinicians theorize that symptoms of long COVID may be at least partially due to the blockage of vessels by microclots, and that the spike protein might be the trigger—which is supported by a recent Harvard Medical School study. If this is the case, nattokinase could be a potential treatment for those suffering from long COVID and its extensive list of symptoms.
Nattokinase’s anti-clotting prowess and ability to dissolve spike proteins could also be helpful with the clotting problems many doctors have observed in those who took the vaccine, and could be a way to dissolve those blood clots before they can do irreparable damage to tissues and organs.
These ingredients are known for their ability to dissolve spike protein, prevent it from binding to cells, and repair tissue.
Recommended to maintain daily health for anyone exposed to COVID, vaccines, or shedding – and may help your body repair itself and remain at optimal health.
Note: To get 10% OFF, please use this coupon code: ONEDAYMD
This would be an advantage for a normal human protein being replaced in a rare genetic deficiency state (e.g., alpha galactosidase in Fabry’s disease). However, it is a big problem when the protein is the pathogenic SARS-CoV-2 spike. The adenoviral DNA (Janssen) should be broken down by deoxyribonuclease, however, this has not been exhaustively studied.
This leaves dissolution of spike protein as a therapeutic goal for the vaccine injured. With the respiratory infection, spike is processed and activated by cellular proteases including transmembrane serine protein 2, cathepsin, and furin. With vaccination, these systems may be avoided by systemic administration and production of spike protein within cells. As a result, the pathogenesis of vaccine injury syndromes is believed to be driven by accumulation of spike protein in cells, tissues, and organs.
Base Spike Detox
According to Dr Peter McCullough (in a Twitter post - July 2023):
Base Spike Detox is what I am currently using in my practice for those
who have had COVID-19 multiple times, one or more of the COVID-19
vaccines, or both and believe persistent SARS-CoV-2 Spike protein could
be causing problems in their body. A major publication is under review
and editing; however, the information is far too important to hold
back.
Update (Nov 2023): Published on August 25, 2023 in Journal of
American Physicians and Surgeons. CLICK HERE FOR THE COMPLETE PAPER
> Base Spike Protein Detoxification and on November 21, 2023 in Cureus (PubMed - November 2023)
I have arrived, based on the emerging scientific literature and my
clinical observation, that three OTC products are essential as a
triple base combination:
- Nattokinase 2000 FU (100 mg) twice a day
- Bromelain 500 mg once a day
- Nano/Liposomal Curcumin 500 mg twice a day
Additional products can be added, including NAC, IVM
(Ivermectin), HCQ (Hydroxychloroquine), fluvoxamine, low-dose
naltrexone, and blood thinners, depending on the clinical
evaluation and the syndrome. The therapeutic objective is to start
treatment and allow the body to clear Spike and its fragments with
the natural reticuloendothelial system. I believe this triple
combination is the best approach.
Patients can get a
big head start if they self-initiate Base Spike Detox as they get
organized for appointments. I have found three months is a minimum
duration, and some require more than a year. Don’t expect instant
results, be patient. I have a major manuscript under review for
publication that summarizes the clinical rationale and evidence
supporting Base Spike Detox.
Important safety warnings
include bleeding for those on blood thinners or who have bleeding
disorders (e.g., hemophilia), soy allergy, allergies to any
component of the combination, and gastrointestinal intolerance.
Women of childbearing potential without contraception, pregnant,
breastfeeding, and children should not take this combination
unless directed by a doctor.
I have arrived, based on the emerging scientific literature and my
clinical observation, that three OTC products are essential as a
triple base combination:
- Nattokinase 2000 FU (100 mg) twice a day
- Bromelain 500 mg once a day
- Nano/Liposomal Curcumin 500 mg twice a day
Additional products can be added, including NAC, IVM
(Ivermectin), HCQ (Hydroxychloroquine), fluvoxamine, low-dose
naltrexone, and blood thinners, depending on the clinical
evaluation and the syndrome. The therapeutic objective is to start
treatment and allow the body to clear Spike and its fragments with
the natural reticuloendothelial system. I believe this triple
combination is the best approach.
Patients can get a big head start if they self-initiate Base Spike Detox as they get organized for appointments. I have found three months is a minimum duration, and some require more than a year. Don’t expect instant results, be patient. I have a major manuscript under review for publication that summarizes the clinical rationale and evidence supporting Base Spike Detox.
Important safety warnings include bleeding for those on blood thinners or who have bleeding disorders (e.g., hemophilia), soy allergy, allergies to any component of the combination, and gastrointestinal intolerance. Women of childbearing potential without contraception, pregnant, breastfeeding, and children should not take this combination unless directed by a doctor.
Patients can get a big head start if they self-initiate Base Spike Detox as they get organized for appointments. I have found three months is a minimum duration, and some require more than a year. Don’t expect instant results, be patient. I have a major manuscript under review for publication that summarizes the clinical rationale and evidence supporting Base Spike Detox.
Important safety warnings include bleeding for those on blood thinners or who have bleeding disorders (e.g., hemophilia), soy allergy, allergies to any component of the combination, and gastrointestinal intolerance. Women of childbearing potential without contraception, pregnant, breastfeeding, and children should not take this combination unless directed by a doctor.
Nattokinase and Spike Protein
What is nattokinase? Nattokinase is an enzyme is produced by fermenting soybeans with the bacteria Bacillus subtilis var. natto and has been available as an oral supplement. It degrades fibrinogen, factor VII, cytokines, and factor VIII and has been studied for its cardiovascular benefits. Out of all the available therapies I have used in my practice and among all the proposed detoxification agents, I believe nattokinase and related peptides hold the greatest promise for patients at this time.
Nattokinase is dosed in fibrinolytic units (FU) per gram and can vary according to purity. Kurosawa and colleagues have shown in humans that after a single oral dose of 2000 FU D-dimer concentrations at six, and eight hours, and blood fibrin/fibrinogen degradation products at four hours after administration elevated significantly (p < 0.05, respectively).
Thus an empiric starting dose could be 2000 FU twice a day. Full pharmacokinetic and pharmacodynamic studies have not been completed, but several years of market use as an over-the-counter supplement suggests nattokinase is safe with the main caveat being excessive bleeding and cautions with concurrent antiplatelet and anticoagulant drugs.
The article makes a claim that 'There is no evidence that
nattokinase dissolves the spike protein of SARS-CoV-2 in the human
body,' while also citing evidence from the Tanikawa study. It's important to acknowledge that the Tanikawa study is a small
lab study, which is a common starting point in the research process
before moving on to larger studies.
Tanikawa et al. examined the effect of nattokinase on the spike protein of
SARS-CoV-2. In the first experiment, they demonstrated that spike was
degraded in a time and dose-dependent manner in a cell lysate
preparation that could be analogous to a vaccine recipient. The second
experiment demonstrated that nattokinase degraded the spike protein in
SARS-CoV-2 infected cells. This was reproduced in a similar study done
by Oba and colleagues in 2021.
Nattokinase is dosed in fibrinolytic units (FU) per gram and can vary according to purity. Kurosawa and colleagues have shown in humans that after a single oral dose of 2000 FU D-dimer concentrations at six, and eight hours, and blood fibrin/fibrinogen degradation products at four hours after administration elevated significantly (p < 0.05, respectively).
Thus an empiric starting dose could be 2000 FU twice a day. Full pharmacokinetic and pharmacodynamic studies have not been completed, but several years of market use as an over-the-counter supplement suggests nattokinase is safe with the main caveat being excessive bleeding and cautions with concurrent antiplatelet and anticoagulant drugs.
Editor's Note: We are aware of a fact-check article
by AFP titled "Experts rubbish Covid vaccine 'detoxification'
supplement". In my humble opinion, the title may come across as
excessively confident and strongly worded.
Nevertheless, we agree that nattokinase is not a miracle drug, and
further research is necessary. It's worth noting that there are more
than 200 studies related to nattokinase published on PubMed.
Moreover, it's essential to recognize that there are multiple
approaches to managing COVID-19. We encourage you to consult with
your trusted healthcare provider to thoroughly discuss and assess
the potential benefits and risks of various possible treatments.
Ivermectin and Spike Protein
Former NIH researcher David Scheim, PhD, early in the pandemic proposed
that SARS-CoV-2 Spike protein was acting like a grappling hook pulling
together circulating red blood cells (RBCs) into long chains and clumps
in a process called hemagglutination (HA).
This explained why the red blood cells could not carry oxygen normally
and was congruent with the finding of micro blood clots in the lungs.
Boschi et al have provided additional support for this mechanism (source). By reversing the clumping of red blood cells, ivermectin enabled the
patient’s proper respiratory function to return.
According to the authors:
“Ivermectin blocked HemAgglutination when added to RBCs prior to
spike protein and reversed HA when added afterwards.”
In another spectacular publication, Stone et al, describes the
prompt improvement of oxygenation in patients with ivermectin (source).
The published oxygenation curves from multiple studies clearly show
this physiological effect of ivermectin occurs so rapidly, it must
be explained by a direct anti-Spike protein effect of ivermectin.
An anonymous video of a critically ill man demonstrates the very effect that Scheim, Stone, Hazan, and
Babalola have described in the Figure above. So for the next
critically ill patient with COVID-19, if the opportunity presents
itself, push for the administration of ivermectin. This is the only
published therapy for COVID-19 that improves oxygen saturation while
the patient mounts a recovery. As in this man, it may be the
critical factor for a turnaround and a chance to walk out of the
hospital.
Former NIH researcher David Scheim, PhD, early in the pandemic proposed
that SARS-CoV-2 Spike protein was acting like a grappling hook pulling
together circulating red blood cells (RBCs) into long chains and clumps
in a process called hemagglutination (HA).
This explained why the red blood cells could not carry oxygen normally
and was congruent with the finding of micro blood clots in the lungs.
Boschi et al have provided additional support for this mechanism (source). By reversing the clumping of red blood cells, ivermectin enabled the
patient’s proper respiratory function to return.
According to the authors:
“Ivermectin blocked HemAgglutination when added to RBCs prior to spike protein and reversed HA when added afterwards.”
In another spectacular publication, Stone et al, describes the
prompt improvement of oxygenation in patients with ivermectin (source).
The published oxygenation curves from multiple studies clearly show
this physiological effect of ivermectin occurs so rapidly, it must
be explained by a direct anti-Spike protein effect of ivermectin.
An anonymous video of a critically ill man demonstrates the very effect that Scheim, Stone, Hazan, and
Babalola have described in the Figure above. So for the next
critically ill patient with COVID-19, if the opportunity presents
itself, push for the administration of ivermectin. This is the only
published therapy for COVID-19 that improves oxygen saturation while
the patient mounts a recovery. As in this man, it may be the
critical factor for a turnaround and a chance to walk out of the
hospital.
Editor's Note:
Why should you trust this article? While we don't ask for blind trust,
we do encourage you to trust in your own judgment. Our primary goal is
to empower you to conduct thorough research and make informed healthcare
decisions in consultation with your trusted medical doctor.
Though there are many spike protein detox treatment protocols out
there, we consider and recommend the I-Recover protocol as one of the best.
Given the lack of clinical trials of long-haul COVID-19 syndrome,
these recommendations are based on the abnormal changes within the
body associated with the COVID-19 disease and post viral illnesses
along with the collective experience of FLCCC members.
This protocol has also been used to treat post-vaccine inflammatory
syndromes with similar success. As with all FLCCC Alliance
protocols, the components, doses, and durations will evolve as more
clinical data accumulates.
Due to the marked overlap between long COVID and post-vaccine
syndrome, please refer to the I-RECOVER Post-Vaccine Treatment protocol for detailed treatment strategies.
Editor's Note:
Why should you trust this article? While we don't ask for blind trust, we do encourage you to trust in your own judgment. Our primary goal is to empower you to conduct thorough research and make informed healthcare decisions in consultation with your trusted medical doctor.
Though there are many spike protein detox treatment protocols out
there, we consider and recommend the I-Recover protocol as one of the best.
Given the lack of clinical trials of long-haul COVID-19 syndrome,
these recommendations are based on the abnormal changes within the
body associated with the COVID-19 disease and post viral illnesses
along with the collective experience of FLCCC members.
This protocol has also been used to treat post-vaccine inflammatory
syndromes with similar success. As with all FLCCC Alliance
protocols, the components, doses, and durations will evolve as more
clinical data accumulates.
Does spike protein stay in body forever?
The Infectious Disease Society of America (IDSA) estimates that the
spike proteins that were generated by COVID-19 vaccines last up to a few weeks, like other proteins made by the body. The immune system quickly
identifies, attacks and destroys the spike proteins because it
recognizes them as not part of you. This "learning the enemy"
process is how the immune system figures out how to defeat the real
coronavirus. It remembers what it saw and when you are exposed to
coronavirus in the future it can rapidly mount an effective immune
response.
However, in a paper published in Clinical Infectious Diseases (Swank 2023), researchers reported detecting a fragment of
SARS-CoV-2 in blood samples from long COVID sufferers up to a year
after their original infection. The fragment is a spike protein, one
of the protrusions around the outside of SARS-CoV-2 that give this
coronavirus its namesake corona, or crownlike appearance. During an
initial COVID infection, the spike protein typically breaks off into
smaller pieces when it penetrates human cells, but the spike proteins
observed in this study were still in one piece.
Although the research on nattokinase and its effect on COVID-19 is still
in its infancy, the ability of nattokinase to degrade spike proteins
combined with its anti-clotting properties makes it an exciting topic for
further study.Some researchers and clinicians theorize that symptoms of long COVID may be at least partially due to the blockage of vessels by microclots, and that the spike protein might be the trigger—which is supported by a recent Harvard Medical School study. If this is the case, nattokinase could be a potential treatment for those suffering from long COVID and its extensive list of symptoms.
Nattokinase’s anti-clotting prowess and ability to dissolve spike proteins could also be helpful with the clotting problems many doctors have observed in those who took the vaccine, and could be a way to dissolve those blood clots before they can do irreparable damage to tissues and organs.
FLCCC protocols
The Front Line COVID-19 Critical Care Alliance has developed
protocols aimed at:
- early treatment (I-Care Protocol)
- prevention (post-vaccine) (I-Prevent)
- long-haul COVID treatment (I-Recover: Long Covid)
- post-vaccine recovery (I-Recover: Post Vaccine)
- hospital treatment (MATH protocol)
To find a list of physicians who follow the protocols and provide
in-office and telehealth services: List of Doctors that will prescribe I-Care Protocol.
To find a list of pharmacist: List of Pharmacies that will fill Ivermectin.
Key Takeaway
Patients should push their doctors to refer them to clinical
trials, and when that is not feasible, then empiric therapy
can be pursued. It is important to realize that in the absence
of completed large randomized placebo controlled randomized
trials, which are easily 5 or more years away in the future,
no therapeutic claims can be made. In the meantime we must be
perceptive as patients and open-minded as clinicians to come
up with reasonable approaches that can be used to help those
sick now with post-COVID syndromes.
Internet Citation: Nattokinase and Spike
Protein Inhibition.
https://covid19.onedaymd.com/2023/02/holy-grail-of-covid-19-spike-protein.html.
References:
Halma, M.T.J.; Plothe, C.; Marik, P.; Lawrie, T.A. Strategies
for the Management of Spike Protein-Related Pathology.
Microorganisms 2023, 11, 1308.
https://doi.org/10.3390/microorganisms11051308
Tanikawa T, Kiba Y, Yu J, Hsu K, Chen S, Ishii A, Yokogawa T, Suzuki R, Inoue Y, Kitamura M. Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2. Molecules. 2022 Aug 24;27(17):5405. doi: 10.3390/molecules27175405. PMID: 36080170; PMCID: PMC9458005.
Tanikawa T, Kiba Y, Yu J, Hsu K, Chen S, Ishii A, Yokogawa T, Suzuki R, Inoue Y, Kitamura M. Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2. Molecules. 2022 Aug 24;27(17):5405. doi: 10.3390/molecules27175405. PMID: 36080170; PMCID: PMC9458005.
62% Normalization in SpO2 within 24 Hours for severe
COVID-19 patients after Ivermectin-Based Combination
Treatment.
Peter A. McCullough’s Substack (Mar 2023)
Peter A. McCullough’s Substack (Mar 2023)
Peter A. McCullough’s Substack (Feb 2023)
The Wellness Company’s Spike Support Formula
The Wellness Company's acclaimed Spike Support Formula contains scientifically-researched ingredients, including nattokinase, black seed oil, green tea extract and selenium.These ingredients are known for their ability to dissolve spike protein, prevent it from binding to cells, and repair tissue.
Recommended to maintain daily health for anyone exposed to COVID, vaccines, or shedding – and may help your body repair itself and remain at optimal health.
Where to buy Spike Support Formula: Spike Support Formula is available on The Wellness Company's
website. Here is the link: Spike Support Formula (Long Haul Formula)
Note: To get 10% OFF, please use this coupon code: ONEDAYMD
Comments
Post a Comment